Tenax Therapeutics Inc
F:YBOC
Tenax Therapeutics Inc
F:YBOC
Precio:
0,101
EUR
32,89%
Capitalización de mercado:
€5,01 M
Agregar nota
Añadir objetivo
Captura tus ideas y establece un objetivo
Decide a qué precio te sentirías cómodo comprando y te ayudaremos a estar preparado.
Basado en
Margen de seguridad
0%
10%
20%
30%
40%
50%
Tu precio objetivo
Vinculado a
precio actual
· En zona de compra
Cargando
Nota vinculada
Elige la acción que deseas seguir con un precio objetivo
Vistos recientemente
|
T
|
Tenax Therapeutics Inc
F:YBOC
|
US |
|
P
|
Platinum Asset Management Ltd
F:PIJ
|
AU |
|
G
|
Geely Automobile Holdings Ltd
F:GRUA
|
HK |
|
I
|
Izotropic Corp
CNSX:IZO
|
CA |
|
Victory Mines Ltd
ASX:VIC
|
AU |
|
Fraport AG Frankfurt Airport Services Worldwide
OTC:FPRUY
|
DE |
|
D
|
Ducommun Inc
SWB:DUM
|
US |
|
C
|
Captor Therapeutics SA
WSE:CTX
|
PL |
|
G
|
Gran Tierra Energy Inc
LSE:GTE
|
CA |
|
M
|
Mersana Therapeutics Inc
F:0M4
|
US |
|
VP Bank AG
SIX:VPBN
|
LI |
|
S
|
Smartone Telecommunications Holdings Ltd
XBER:SMA
|
HK |
Reverse DCF
Market Expectations:
Unrealistic
To justify the current price, Netflix Inc. must grow revenue by 36% annually over the next 5 years, which is outside the range of what's considered realistic.
| Revenue Growth Rate | DCF Value | |
|---|---|---|
|
Realistic Range
|
Realistic Low: 10%
|
$601.26
Overvalued by 45%
|
|
Historical: 21%
|
$758.26
Overvalued by 36%
|
|
|
Current DCF: 23%
|
$789.44
Overvalued by 32%
|
|
|
Wall Street: 24%
|
$831.32
Overvalued by 28%
|
|
|
Realistic High: 30%
|
$900.12
Overvalued by 12%
|
|
|
Implied by Price: 36%
|
$977.59
Matches Stock Price
|
Below current price
Above current price
